Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 14 citing articles:

Surgical Management of Gastroenteropancreatic Neuroendocrine Tumors
Lisa M. Kenney, Marybeth S. Hughes
Cancers (2025) Vol. 17, Iss. 3, pp. 377-377
Open Access | Times Cited: 1
Prodrugs in Oncology: Bioactivation and Impact on Therapeutic Efficacy and Toxicity
Ritika Kurian, Hongbing Wang
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 988-988
Open Access | Times Cited: 1
Opposing Effects of Cannabidiol in Patient-derived Neuroendocrine Tumor, Pheochromocytoma/Paraganglioma Primary Cultures
Katharina Wang, Laura Schober, Alessa Fischer, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 5
The Factors Associated with All-Cause In-Hospital Mortality in Patients with Malignant Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: A Retrospective Analysis of the National Inpatient Survey (Nis)
Elvis Obomanu, Tarfa Verinumbe, Hasiya Yusuf, et al.
(2025)
Closed Access
Reflections on the Demand for PSMA- and SSTR-Targeted Radiopharmaceutical Therapies: Why We Were Wrong (and Why We Will Be Right Eventually)
Johannes Czernin, Lisa Bodei, Irvin M. Modlin, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.269401-jnumed.124.269401
Closed Access
An angiogenic proteome study of black raspberry extract on neuroendocrine cancers
B. Gentile, J Mehrez, Tomica Milosavljević, et al.
Deleted Journal (2025), pp. 200198-200198
Open Access
Prediction of lesion-based response to PRRT using baseline somatostatin receptor PET
Anas Aouf, Tilman Speicher, Arne Blickle, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Beyond similarities: overall survival and prognostic insights from [¹⁷⁷Lu]Lu-DOTATOC therapy in neuroendocrine tumors
Tristan Ruhwedel, Julian M.M. Rogasch, Imke Schatka, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access
Survival Benefits of GLP-1 Receptor Agonists in Patients with Neuroendocrine Neoplasms: A Large-Scale Propensity-Matched Cohort Study
Manal S. Fawzy, Awwad Alenezy, Jessan A. Jishu, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1593-1593
Open Access
Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline
Kimberly Perez, Jaydira Del Rivero, Erin B. Kennedy, et al.
JCO Oncology Practice (2025)
Closed Access
Last decade of advances in gastric neuroendocrine tumors: Innovations, challenges, and future directions
Grigorios Christodoulidis, Marina Nektaria Kouliou, Dimitrios Ragias, et al.
World Journal of Clinical Oncology (2025) Vol. 16, Iss. 5
Closed Access
Systemic Inflammatory Regulators Associated with Osteoporosis: A Bidirectional Mendelian Randomization Study
Lei Xu, Hui Li, Bin Liu, et al.
Calcified Tissue International (2024) Vol. 114, Iss. 5, pp. 490-501
Closed Access | Times Cited: 3
Update on the classification and diagnostic approach of pituitary neuroendocrine tumours
Federico Roncaroli, Carmine Antonio Donofrio, Liam Walker, et al.
Diagnostic histopathology (2024) Vol. 30, Iss. 12, pp. 668-679
Closed Access
Temozolomide and capecitabine regimen as first-line treatment in advanced gastroenteropancreatic neuroendocrine tumors at a Latin American reference center
Wagner Eduardo Cruz-Diaz, Victor Paitan, Jesús R. Medina, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 12, pp. 4675-4684
Closed Access
Page 1

Scroll to top